7900 E. UNION AVENUE, DENVER, CO
Termination of Material Definitive Agreement - AYTU Biopharma, Inc.
Reports Fiscal 2026 Third Quarter Operational and Financial Results
Earnings Release
Reports Fiscal 2026 Second Quarter Operational and Financial Results
Reg. FD
Election of Directors and Appointment of Accounting Firm at Aytu Biopharma
Reports Fiscal 2026 First Quarter Operational and Financial Results
Annual Report to Security Holders
Q3
Q2
Q1
FY 2025
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
Effectiveness Notice
S-1
Direct Registration System
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership